A recent BBC article has shone a spotlight on the “massively misdiagnosed” 22q deletion syndrome. This genetic condition can cause a range of mild to severe behavioural, psychological and physical symptoms, but often flies under the radar in babies and children.
A Phase 1 clinical trial has investigated the effect of umbilical cord-derived MSCs on the immune systems of Lupus patients. Although the study was small, positive results were observed 24 weeks post-treatment.
A new study suggests that umbilical cord tissue could one day be used to treat chronic, non-healing diabetic foot ulcers. EpiCord, a thick membrane product produced from umbilical cords, has been studied and tested as a form of wound dressing and healing for the ulcers.